ID

12028

Beschreibung

Functional MR-guided Stereotactic Body Radiation Therapy of Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01976962 Principal Investigator: Harvey Quon, MD CancerCare Manitoba

Link

https://clinicaltrials.gov/show/NCT01976962

Stichworte

  1. 01.09.15 01.09.15 -
Hochgeladen am

1. September 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Prostatic Neoplasms NCT01976962

Eligibility Prostatic Neoplasms NCT01976962

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI-1
C1512693
Informed consent
Beschreibung

Informed consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
Age >18 years
Beschreibung

Age >18 years

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
Beschreibung

Histologically confirmed and centrally reviewed prostate adenocarcinoma based

Datentyp

boolean

Alias
UMLS CUI [1]
C0007112
PSA within 60 days
Beschreibung

PSA within 60 days

Datentyp

boolean

Alias
UMLS CUI [1]
C0138741
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
Beschreibung

High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.

Datentyp

boolean

Alias
UMLS CUI [1]
C0332167
UMLS CUI [2]
C0600139
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI-1
C0680251
Evidence of lymph node metastasis
Beschreibung

Evidence of lymph node metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0024204
UMLS CUI [2]
C0027627
Evidence of distant metastases
Beschreibung

Evidence of distant metastases

Datentyp

boolean

Alias
UMLS CUI [1]
C0027627
UMLS CUI [2]
C0443203
Prior pelvic radiotherapy or brachytherapy
Beschreibung

Prior pelvic radiotherapy or brachytherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0436276
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
Beschreibung

Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound

Datentyp

boolean

Alias
UMLS CUI [1]
C0033573
Unable to undergo gold seed insertion
Beschreibung

Unable to undergo gold seed insertion

Datentyp

boolean

Alias
UMLS CUI [1]
C1960738
Immunosuppressive medications
Beschreibung

Immunosuppressive medications

Datentyp

boolean

Alias
UMLS CUI [1]
C0021081
Inflammatory bowel disease
Beschreibung

Inflammatory bowel disease

Datentyp

boolean

Alias
UMLS CUI [1]
C0021390
Unable to undergo MRI
Beschreibung

Unable to undergo MRI

Datentyp

boolean

Alias
UMLS CUI [1]
C0024485
Previous bilateral orchiectomy
Beschreibung

Previous bilateral orchiectomy

Datentyp

boolean

Alias
UMLS CUI [1]
C0029189
UMLS CUI [2]
C0238767
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
Beschreibung

Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens

Datentyp

boolean

Alias
UMLS CUI [1]
C0279025
Previous finasteride within 14 days.
Beschreibung

Previous finasteride within 14 days.

Datentyp

boolean

Alias
UMLS CUI [1]
C0060389
Previous dutasteride within 180 days.
Beschreibung

Previous dutasteride within 180 days.

Datentyp

boolean

Alias
UMLS CUI [1]
C0754659

Ähnliche Modelle

Eligibility Prostatic Neoplasms NCT01976962

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Inclusion Criteria
C1512693 (UMLS CUI-1)
informed consent
Item
Informed consent
boolean
C0021430 (UMLS CUI [1])
age
Item
Age >18 years
boolean
C0001779 (UMLS CUI [1])
prostate adenocarcinoma
Item
Histologically confirmed and centrally reviewed prostate adenocarcinoma based
boolean
C0007112 (UMLS CUI [1])
psa
Item
PSA within 60 days
boolean
C0138741 (UMLS CUI [1])
high risk; Prostate carcinoma
Item
High risk prostate cancer defined as any one of: clinical stage >= T3, Gleason score >= 8, or PSA >=20 and <50 ng/mL.
boolean
C0332167 (UMLS CUI [1])
C0600139 (UMLS CUI [2])
Item Group
Exclusion Criteria
C0680251 (UMLS CUI-1)
lymph nodes; metastasis
Item
Evidence of lymph node metastasis
boolean
C0024204 (UMLS CUI [1])
C0027627 (UMLS CUI [2])
metastases; distant
Item
Evidence of distant metastases
boolean
C0027627 (UMLS CUI [1])
C0443203 (UMLS CUI [2])
pelvic radiotherapy
Item
Prior pelvic radiotherapy or brachytherapy
boolean
C0436276 (UMLS CUI [1])
prostatectomy
Item
Previous radical prostatectomy, cryotherapy, or high-frequency ultrasound
boolean
C0033573 (UMLS CUI [1])
Implantation of radioactive seed into prostate
Item
Unable to undergo gold seed insertion
boolean
C1960738 (UMLS CUI [1])
Immunosuppressive Agents
Item
Immunosuppressive medications
boolean
C0021081 (UMLS CUI [1])
Inflammatory bowel disease
Item
Inflammatory bowel disease
boolean
C0021390 (UMLS CUI [1])
mri
Item
Unable to undergo MRI
boolean
C0024485 (UMLS CUI [1])
orchiectomy; bilateral
Item
Previous bilateral orchiectomy
boolean
C0029189 (UMLS CUI [1])
C0238767 (UMLS CUI [2])
hormonal therapy
Item
Previous hormonal therapy including LHRH agonists (leuprolide, goserelin), LHRH antagonists (degarelix), anti-androgens (bicalutamide, flutamide, nilutamide), surgical castration, and estrogens
boolean
C0279025 (UMLS CUI [1])
finasteride
Item
Previous finasteride within 14 days.
boolean
C0060389 (UMLS CUI [1])
dutasteride
Item
Previous dutasteride within 180 days.
boolean
C0754659 (UMLS CUI [1])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video